FP
MDT icon

Foundry Partners’s Medtronic MDT Stock Holding History

Foundry Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$22.8M Sell
253,879
-14,432
-5% -$1.29M 1.21% 19
2024
Q4 		$21.4M Buy
268,311
+679
+0.3% +$58.8K 1.08% 22
2024
Q3 		$24.1M Sell
267,632
-1,348
-0.5% -$113K 1.19% 18
2024
Q2 		$21.2M Buy
268,980
+104,929
+64% +$8.6M 1.14% 19
2024
Q1 		$14.3M Buy
+164,051
New +$14M 0.76% 36
2022
Q2 		– Sell
-168,965
Closed -$18.7M – 340
2022
Q1 		$18.7M Sell
168,965
-3,925
-2% -$415K 0.96% 38
2021
Q4 		$17.9M Sell
172,890
-3,175
-2% -$368K 0.63% 56
2021
Q3 		$22.1M Sell
176,065
-1,925
-1% -$249K 0.79% 30
2021
Q2 		$22.1M Sell
177,990
-2,125
-1% -$267K 0.76% 28
2021
Q1 		$21.3M Buy
180,115
+13,650
+8% +$1.6M 0.7% 30
2020
Q4 		$19.5M Buy
+166,465
New +$18.3M 0.77% 27
2020
Q2 		– Sell
-194,550
Closed -$17.5M – 403
2020
Q1 		$17.5M Buy
194,550
+675
+0.3% +$71.8K 0.99% 13
2019
Q4 		$22M Buy
193,875
+77,616
+67% +$8.52M 0.83% 19
2019
Q3 		$12.6M Sell
116,259
-7,650
-6% -$798K 0.52% 63
2019
Q2 		$12.1M Buy
+123,909
New +$11.3M 0.47% 64
2017
Q2 		– Sell
-5,154
Closed -$415K – 432
2017
Q1 		$415K Sell
5,154
-1,558
-23% -$122K 0.02% 385
2016
Q4 		$478K Sell
6,712
-22,314
-77% -$1.75M 0.02% 382
2016
Q3 		$2.51M Sell
29,026
-3,237
-10% -$282K 0.13% 231
2016
Q2 		$2.8M Sell
32,263
-5,015
-13% -$406K 0.16% 219
2016
Q1 		$2.8M Sell
37,278
-56,220
-60% -$4.23M 0.28% 118
2015
Q4 		$7.19M Buy
93,498
+7,173
+8% +$540K 0.6% 55
2015
Q3 		$5.78M Sell
86,325
-11,370
-12% -$837K 0.51% 75
2015
Q2 		$7.24M Sell
97,695
-5,253
-5% -$401K 0.58% 59
2015
Q1 		$8.03M Buy
+102,948
New +$7.8M 0.67% 53

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Foundry Partners's MDT Position: Q1 2025 in Review

Foundry Partners reduced its Medtronic (MDT) stake by 5.4% in Q1 2025, selling an estimated $1.29M and leaving 253,879 shares worth $22.8M. The position accounts for 1.21% of the portfolio, ranked #19.

Foundry Partners first reported a position in MDT in Q1 2015 and has held it in 24 quarters since. The position peaked at $24.1M in Q3 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Foundry Partners held 253,879 shares of Medtronic worth $22.8M as of Q1 2025.
  • Foundry Partners sold 14,432 Medtronic shares in Q1 2025, an estimated $1.29M.
  • Medtronic made up 1.21% of Foundry Partners's portfolio in Q1 2025, its #19 holding.
  • Foundry Partners first reported a position in Medtronic in Q1 2015 and has held it in 24 quarters since.
  • Foundry Partners's Medtronic position peaked at $24.1M in Q3 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.